Dexia Eq l Biotechnology Cap
5 Year Return (Annualized)30.73%
ClassificationEquity Sector Biotechnology
Manager BenchmarkS&P 500 TR
Lipper Leader Profile (Overall)
The Growth of 10, 000USD chart includes reinvestment of dividends and capital gains, but does not reflect the effect of any applicable sales or redemption charges which would lower these figures.
|Portfolio Manager||Candriam France SA|
Fees, Expenses, & Minimums
|Early Redemption Fee|
|Total Net Assets||840.70 M USD|
|Total Net Assets Date|
|Annual Max Charge||1.50%|
|Annual Min Charge|
The fund invests mainly in equity issued by companies from biotechnology sector, from all over the world.
About the ratings...
Total Return reflects the fund's historical total return performance relative to its peers. Consistent Return reflects the funds's historical risk-adjusted returns relative to its peers. The Capital Preservation is relative, rather that absolute...
Laser Genetics ND3-Bow Subzero LASER Designator with Bow and Scope Mount
Sports (Laser Genetics)
Edvotek 119 Genes in a Tube, For 26 Students
Aircool Men's Summer Daily Recreational Breathable Leisure Shoes Black Size US8